|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C08B 37/00 | (2006.01) |
| A61K 39/095 | (2006.01) | ||
| A61K 47/50 | (2017.01) | ||
| C07H 13/00 | (2006.01) |
| (11) | Number of the document | 2118145 |
| (13) | Kind of document | T |
| (96) | European patent application number | 08737594.5 |
| Date of filing the European patent application | 2008-01-11 | |
| (97) | Date of publication of the European application | 2009-11-18 |
| (45) | Date of publication and mention of the grant of the patent | 2017-05-17 |
| (46) | Date of publication of the claims translation | 2017-08-25 |
| (86) | Number | PCT/IB2008/001116 |
| Date | 2008-01-11 |
| (87) | Number | WO 2008/084411 |
| Date | 2008-07-17 |
| (30) | Number | Date | Country code |
| 0700562 | 2007-01-11 | GB |
| (72) |
BARDOTTI, Angela, IT
BERTI, Francesco, IT
COSTANTINO, Paolo, IT
|
| (73) |
GlaxoSmithKline Biologicals SA,
Rue de l`Institut 89, 1330 Rixensart,
BE
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Modifikuoti sacharidai |
| MODIFIED SACCHARIDES |
| Payment date | Validity (years) | Amount | |
| 2024-12-18 | 18 | 347.00 EUR |
| 2026-01-11 |